BackIntelligent Medicine Acquisition Overview

Intelligent Medicine Acquisition Total Liabilities

Intelligent Medicine Acquisition's total liabilities is $12M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$11.64M
44.61% YoYΔ $-9.37M vs prior year quarter

Peer average

Loading

Intelligent Medicine Acquisition Total Liabilities History

Loading

Intelligent Medicine Acquisition vs. peers: Total Liabilities Comparison

Loading

Intelligent Medicine Acquisition Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Intelligent Medicine Acquisition (IQMD) FAQ

Intelligent Medicine Acquisition (IQMD) currently reports a total liabilities of $12M as of December 2022. That compares with $21M in the prior-year period — down 44.6% year over year. Use the charts on this page to explore Intelligent Medicine Acquisition's total liabilities history and peer comparisons.

Intelligent Medicine Acquisition's total liabilities decreased from $21M to $12M — a 44.6% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Intelligent Medicine Acquisition reported $12M in total liabilities as of December 2022. That compares with $21M in the prior-year period — down 44.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Intelligent Medicine Acquisition, and consider following IQMD for alerts when major investors trade the stock.